You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 7, July 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •eTables
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Dementias
 •Neurogenetics
 •Stroke
 •Neurology, Other
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Genetic Disorders
 •Genetics, Other
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Genomic Susceptibility Loci for Brain Atrophy, Ventricular Volume, and Leukoaraiosis in Hypertensive Sibships

Stephen T. Turner, MD; Myriam Fornage, PhD; Clifford R. Jack Jr, MD; Thomas H. Mosley, PhD; David S. Knopman, MD; Sharon L. R. Kardia, PhD; Eric Boerwinkle, PhD; Mariza de Andrade, PhD

Arch Neurol. 2009;66(7):847-857.

Objective  To localize susceptibility genes for alterations in brain structure associated with risk of stroke and dementia. We conducted genomewide linkage analyses for magnetic resonance imaging (MRI) measures of brain atrophy, ventricular, and subcortical white matter hyperintensity (leukoaraiosis) in 689 non-Hispanic white (673 sibling pairs; median age, 61 years) and 544 non-Hispanic black participants (503 sibling pairs; median age, 64 years) from sibships with at least 2 members with essential hypertension.

Design, Setting, and Patients  We determined brain, ventricular, and leukoaraiosis volumes from axial fluid-attenuated inversion recovery MRI; we calculated brain atrophy as the difference between total intracranial and brain volumes. Microsatellite markers (n = 451) distributed across the 22 autosomes were genotyped, and we used variance components methods to estimate heritability and assess evidence of genetic linkage for each MRI measure.

Main Outcome Measures  Brain atrophy ventricular volume, and leukoaraiosis determined from fluid-attenuated inversion recovery MRI.

Results  In both races, the heritability of each MRI measure was statistically greater than 0 (P < .001), ranging in magnitude from 0.42 (for ventricular volume in blacks) to 0.69 (for brain atrophy in blacks). Based on multipoint logarithm of odds scores (MLS), the strongest evidence of genetic linkage was observed for brain atrophy on chromosomes 1 (MLS, 3.49 at 161 cM; P < .001) and 17 (MLS, 3.08 at 18 cM; P < .001) in whites; for ventricular volume on chromosome 12 (MLS, 3.67 at 49 cM; P < .001) in blacks and chromosome 10 (MLS, 2.47 at 110 cM; P < .001) in whites; and for leukoaraiosis on chromosome 11 (MLS, 2.21 at 118 cM; P < .001) in whites and chromosome 22 (MLS, 2.02 at 36 cM; P = .001) in blacks.

Conclusions  The MRI measures of structural brain injury are heritable in non-Hispanic black and white sibships ascertained through hypertensive sibling pairs. The susceptibility loci for brain atrophy, ventricular volume, and leukoaraiosis identified by linkage analyses differ among MRI measures and between races.


Author Affiliations: Division of Nephrology and Hypertension, Department of Internal Medicine (Dr Turner), Department of Diagnostic Radiology (Dr Jack), Department of Neurology (Dr Knopman), and Division of Biostatistics, Department of Health Sciences Research (Dr de Andrade), Mayo Clinic and Foundation, Rochester, Minnesota; Human Genetics Center and Institute of Molecular Medicine, University of Texas–Houston Health Science Center (Drs Fornage and Boerwinkle); Division of Geriatric Medicine, Department of Medicine, University of Mississippi Medical Center, Jackson (Dr Mosley); and Department of Epidemiology, University of Michigan, Ann Arbor, Michigan (Dr Kardia).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(7):817-818.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Advances in Vascular Cognitive Impairment
Gorelick and Bowler
Stroke 2010;41:e93-e98.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.